Alyeska Investment Group’s Windtree Therapeutics Inc WINT Stock Holding History

Alyeska Investment Group’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-680,570	Closed	-$776K	–	619
2017 Q1	$776K	Buy	680,570 +502,000	+281%	+$652K	0.01%	443
2016 Q4	$223K	Hold	178,570	–	–	﹤0.01%	457
2016 Q3	$457K	Hold	178,570	–	–	﹤0.01%	433
2016 Q2	$345K	Hold	178,570	–	–	﹤0.01%	411
2016 Q1	$298K	Sell	178,570 -1	-0%	-$2	﹤0.01%	372
2015 Q4	$7.49M	Hold	178,571	–	–	0.08%	236
2015 Q3	$750K	Buy	+178,571	New	+$1.18M	0.01%	407

Other funds holding WINT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Alyeska Investment Group's WINT Position: Q2 2017 in Review

Alyeska Investment Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 459,364 shares — an estimated $524K sold.

Alyeska Investment Group first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $3.89M in Q1 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

Alyeska Investment Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
Alyeska Investment Group sold 459,364 Windtree Therapeutics Inc shares in Q2 2017, an estimated $524K.
Alyeska Investment Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
Alyeska Investment Group's Windtree Therapeutics Inc position peaked at $3.89M in Q1 2014.
3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.